We are advancing research across several neurologic disorders, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and stroke.
We are resolute in our commitment to help those living with and
affected by the realities of neurologic diseases. We strive to
preserve personhood in the face of unrelenting challenges. We stand
with patients, their families and healthcare providers to navigate
neuroscience’s unchartered frontiers and inevitable setbacks to
deliver science that will make a meaningful difference and a
remarkable impact on people’s lives.
Living with a Neurodegenerative Disease
At AbbVie, we invest in neuroscience research that identifies opportunities to help people who live with neurologic disorders, such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and stroke. We are committed to investing in research that identifies opportunities for real modification, delivering pioneering science, built on inevitable setbacks, that will make a meaningful difference for patients.
On May 18, 2016, we opened a 43,000-square-foot Cambridge Research
Center in Cambridge, Massachusetts. At the Cambridge Research Center,
we will undergo research to gain a deeper understanding of the
biological mechanisms underlying neurodegenerative diseases.
Learn more about our commitment to help those living with and affected by neurologic diseases.
Alzheimer’s disease
Multiple sclerosis
Parkinson’s
disease
Stroke
We invest in research that identifies opportunities for real modification – delivering science that will make a meaningful difference in people’s lives.